Merck Keytruda, Chemotherapy combo meets endpoint for first-line treatment of Breast Cancer Medical Dialogues Bureau18 Feb 2020 10:15 AM ISTNew Delhi: Merck known as MSD outside the United States and Canada, recently announced that the pivotal Phase 3 KEYNOTE-355 trial investigating...
AbbVie gets positive CHMP Opinion for VENCLYXTO for Leukemia patients Medical Dialogues Bureau8 Feb 2020 10:00 AM ISTNew Delhi: AbbVie , a research-based global biopharmaceutical company, announced recently that the Committee for Medicinal Products for Human Use...
Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug Medical Dialogues Bureau6 Nov 2019 10:32 AM ISTZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial Medical Dialogues Bureau3 Nov 2019 9:00 AM ISTBristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
GSK ovarian cancer drug Zejula gets USFDA nod for wider use Medical Dialogues Bureau24 Oct 2019 10:00 AM ISTZejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study Medical Dialogues Bureau8 Sept 2019 9:15 AM ISTThe drug, Opdivo, when used along with the current standard of care for glioblastoma multiforme, did not prevent cancer from spreading when compared...
Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta Medical Dialogues Bureau31 Aug 2019 9:30 AM ISTAlimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel Medical Dialogues Bureau28 July 2019 9:17 AM ISTSales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer Medical Dialogues Bureau12 Jun 2019 9:50 AM ISTThe approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit Medical Dialogues Bureau12 Jun 2019 9:30 AM ISTRoche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
Roche gets USFDA nod for combo lymphoma treatment Polivy Medical Dialogues Bureau11 Jun 2019 9:30 AM ISTPolivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine Farhat Nasim22 May 2019 9:45 AM ISTAzacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
